Cindy X. Cai

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis

Cindy X. Cai, Hema Buddha, Shobha Castelino‐Prabhu et al. · Digestive Diseases and Sciences · 2017 · 71 citations

Insulin-pi3k/akt-p70s6k Pathway, Hepatic Stellate Cells, Pathology +17

Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin

Zhiwei Zhang, Geetha Maddukuri, Navin Jaipaul et al. · Journal of Critical Care · 2015 · 61 citations

Type 1, Urology, Renal Function +10

Kidney injury molecule-1 (KIM-1) mediates renal epithelial cell repair via ERK MAPK signaling pathway

Zhiwei Zhang, Cindy X. Cai · Molecular and Cellular Biochemistry · 2016 · 59 citations · Full text

Urology, Signal Transduction, Signaling Pathway +11

Targeting an Early and Substantial Increase in Mean Arterial Pressure Is Critical in the Management of Type 1 Hepatorenal Syndrome: A Combined Retrospective and Pilot Study

Geetha Maddukuri, Cindy X. Cai, Satish Munigala et al. · Digestive Diseases and Sciences · 2013 · 27 citations

Type 1, Hypertension, Hepatology +11